Original Research
Published on 30 Oct 2020
Cost-Effectiveness of Gliclazide-Based Intensive Glucose Control vs. Standard Glucose Control in Type 2 Diabetes Mellitus. An Economic Analysis of the ADVANCE Trial in Vietnam
in Health Economics
Frontiers in Public Health
doi 10.3389/fpubh.2020.562023
- 7,674 views
- 3 citations

